- Home
- TLPH vs DSS Comparison
TLPH vs DSS Comparison
Compare TLPH & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- DSS
- Stock Information
- Founded
- TLPH 2005
- DSS 1984
- Country
- TLPH United States
- DSS United States
- Employees
- TLPH N/A
- DSS N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- TLPH Health Care
- DSS Consumer Discretionary
- Exchange
- TLPH Nasdaq
- DSS Nasdaq
- Market Cap
- TLPH 10.6M
- DSS 8.9M
- IPO Year
- TLPH 2011
- DSS N/A
- Fundamental
- Price
- TLPH $0.44
- DSS $0.95
- Analyst Decision
- TLPH Strong Buy
- DSS
- Analyst Count
- TLPH 1
- DSS 0
- Target Price
- TLPH $6.00
- DSS N/A
- AVG Volume (30 Days)
- TLPH 31.7K
- DSS 13.0K
- Earning Date
- TLPH 08-13-2025
- DSS 08-12-2025
- Dividend Yield
- TLPH N/A
- DSS N/A
- EPS Growth
- TLPH N/A
- DSS N/A
- EPS
- TLPH N/A
- DSS N/A
- Revenue
- TLPH $27,000.00
- DSS $20,180,000.00
- Revenue This Year
- TLPH N/A
- DSS N/A
- Revenue Next Year
- TLPH $14,533.26
- DSS N/A
- P/E Ratio
- TLPH N/A
- DSS N/A
- Revenue Growth
- TLPH N/A
- DSS 12.88
- 52 Week Low
- TLPH $0.44
- DSS $0.72
- 52 Week High
- TLPH $1.19
- DSS $1.75
- Technical
- Relative Strength Index (RSI)
- TLPH 31.91
- DSS 53.55
- Support Level
- TLPH $0.45
- DSS $0.88
- Resistance Level
- TLPH $0.52
- DSS $0.98
- Average True Range (ATR)
- TLPH 0.03
- DSS 0.05
- MACD
- TLPH -0.00
- DSS 0.01
- Stochastic Oscillator
- TLPH 0.00
- DSS 80.00
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.